Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide

Por Behl, Ajay S., Ellis, Lorie A., Pilon, Dominic, Xiao, Yongling, Lefebvre, Patrick
Publicado no Am Health Drug Benefits (2017)

Real-World Corticosteroid Utilization Patterns in Patients with Metastatic Castration-Resistant Prostate Cancer in 2 Large US Administrative Claims Databases

Por Lafeuille, Marie-Hélène, Gravel, Jonathan, Grittner, Amanda, Lefebvre, Patrick, Ellis, Lorie, McKenzie, R. Scott
Publicado em 2013

Treatment Sequences and Pharmacy Costs of 2 New Therapies for Metastatic Castration-Resistant Prostate Cancer

Por Ellis, Lorie A., Lafeuille, Marie-Hélène, Gozalo, Laurence, Pilon, Dominic, Lefebvre, Patrick, McKenzie, Scott
Publicado no Am Health Drug Benefits (2015)

Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy

Por Pilon, Dominic, Behl, Ajay S., Ellis, Lorie A., Robitaille, Marie-Noëlle, Lefebvre, Patrick, Dawson, Nancy A.
Publicado no Am Health Drug Benefits (2017)

Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs

Por Lofland, Jennifer H, Johnson, Phaedra T, Ingham, Mike P, Rosemas, Sarah C, White, John C, Ellis, Lorie
Publicado no Patient Prefer Adherence (2017)